GlassScriptPhysician profile
Jill Mcdonald
NPI 1528712841
$1,523.71
in general payments reported to CMS, 2019-2025
21 companies · $770 in 2025
The $770 reported for 2025 was more than what 93% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $138 · 2023: $219 · 2024: $396 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,291 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,291.36 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $363.02 | 2023-2025 | Veozah |
| Biogen, INC. | $203.27 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $117.19 | 2022-2025 | |
| Organon LLC | $106.27 | 2022-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $96.59 | 2022-2025 | |
| Exeltis, USA INC. | $91.18 | 2024-2025 | Slynd |
| Shield Therapeutics INC | $82.12 | 2024-2025 | |
| Daiichi Sankyo INC. | $78.83 | 2022-2025 | Injectafer |
| Exact Sciences Corporation | $67.78 | 2023-2024 | Cologuard Collection Kit |
| Millicent US INC | $67.10 | 2023-2024 | Intrarosa, Femring |
| Abbvie INC. | $64.93 | 2023-2025 | |
| Conmed Corporation | $37.61 | 2025 | Airseal |
| Mylan Pharmaceuticals INC. | $25.82 | 2022 | |
| Lsi Solutions INC | $17.70 | 2024 | Fornisee |
| Ethicon US, LLC | $16.52 | 2025 | Stratafix, Dermabond Prineo, Vistaseal |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $15.74 | 2023 | Fluent Fluid Management System, Myosure Tissue Removal Device |
| Olympus America INC. | $15.60 | 2022 | |
| Medtronic, INC. | $15.05 | 2023 | Interstim |
| Evofem Biosciences, INC. | $14.43 | 2022 | |
| Sumitomo Pharma America, INC. | $13.89 | 2025 | Myfembree |
| Convatec INC. | $13.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.